journal
https://read.qxmd.com/read/37529372/new-media-platforms-for-teaching-and-networking-emerging-global-opportunities-for-breast-surgeons
#1
REVIEW
Muskaan Khosla, Raghavan Vidya, Ashutosh Kothari, Bahadir M Gulluoglu
BACKGROUND: The framework of breast care is changing rapidly due to the increasing success of systemic therapies for breast cancer, and consequently, surgeons need to adapt themselves to the changing role of surgery in its management. Real-world evidence indicates that breast cancer patient-related outcomes are better if they are managed by specialized physicians and surgeons. On the other hand, the curriculum for the training of breast surgeons is expanding and includes skills that involve newer surgical techniques and nonsurgical technologies...
June 2023: Breast Care
https://read.qxmd.com/read/37529371/phytoestrogen-treatment-for-menopausal-vasomotor-symptoms-after-breast-cancer
#2
JOURNAL ARTICLE
Marie Vogel, Sebastian Franik, Ludwig Kiesel
INTRODUCTION: In breast cancer patients, menopausal symptoms are often reached earlier and in a more severe manner than in healthy women. They can dramatically reduce a patient's quality of life. Treatment for breast cancer patients remains difficult due to hormone replacement therapy being contraindicated. Therefore, treatment alternatives like herbal phytoestrogen preparations are considered to be a treatment option. METHODS: All randomized controlled trials (RCTs) that investigated comparisons of food products, extracts, or dietary supplements containing phytoestrogens in women with a diagnosis of breast cancer were included in the analysis...
June 2023: Breast Care
https://read.qxmd.com/read/37529370/clinical-importance-of-pgrmc1-in-hormone-responsive-breast-cancer
#3
REVIEW
Xiangyan Ruan, Alfred O Mueck
BACKGROUND: For the development of PGRMC1, a multifunctional receptor belonging to membrane-associated progesterone receptor proteins (MAPR) family, as possible predictive marker for increased hormone-dependent breast cancer (BC) risk, a systematic research program has been performed, starting with different BC cells, continued with animal studies and finally with clinical studies with BC patients. SUMMARY: In vitro studies showed dose- and time-dependent BC cell proliferations with all available synthetic progestogens (not with progesterone), but mostly significant only in the presence of PGRMC1...
June 2023: Breast Care
https://read.qxmd.com/read/37529369/augmented-reality-in-breast-surgery-education
#4
JOURNAL ARTICLE
Pedro F Gouveia, Rogélio Luna, Francisco Fontes, David Pinto, Carlos Mavioso, João Anacleto, Rafaela Timóteo, João Santinha, Tiago Marques, Fátima Cardoso, Maria João Cardoso
INTRODUCTION: Augmented reality (AR) has demonstrated a potentially wide range of benefits and educational applications in the virtual health ecosystem. The concept of real-time data acquisition, machine learning-aided processing, and visualization is a foreseen ambition to leverage AR applications in the healthcare sector. This breakthrough with immersive technologies like AR, mixed reality, virtual reality, or extended reality will hopefully initiate a new surgical era: that of the use of the so-called surgical metaverse...
June 2023: Breast Care
https://read.qxmd.com/read/37261134/prevalence-of-pathogenic-germline-variants-in-women-with-non-familial-unilateral-triple-negative-breast-cancer
#5
JOURNAL ARTICLE
Kerstin Rhiem, Silke Zachariae, Anke Waha, Sabine Grill, Anna Hester, Michael Golatta, Marion van Mackelenbergh, Tanja Fehm, Tanja Schlaiß, Tim Ripperger, Susanne Ledig, Cornelia Meisel, Dorothee Speiser, Kristina Veselinovic, Christopher Schröder, Isabell Witzel, Julia Gallwas, Bernhard H F Weber, Christine Solbach, Bariyhe Aktas, Eric Hahnen, Christoph Engel, Rita Schmutzler
INTRODUCTION: International guidelines recommend genetic testing for women with familial breast cancer at an expected prevalence of pathogenic germline variants (PVs) of at least 10%. In a study sample of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC), we have previously shown that women with TNBC diagnosed before the age of 50 years but without a family history of breast or ovarian cancer (sTNBC) meet this criterion. The present study investigates the PV prevalence in BRCA1, BRCA2, and nine additional cancer predisposition genes in an extended sTNBC study sample including a cohort of women with a later age at sTNBC diagnosis...
May 2023: Breast Care
https://read.qxmd.com/read/37261133/ultrasound-measurement-of-the-distance-between-the-breast-tumor-and-the-skin-a-cut-off-value-for-safe-skin-preservation-diagnostic-accuracy-study
#6
JOURNAL ARTICLE
Rodrigo Gregório Brandão, Simone Elias, Ângela Flavia Logullo Waitzberg, Gil Facina, Vanessa Monteiro Sanvido, Afonso Celso Pinto Nazário
BACKGROUND: In superficial tumors of the breast, it is necessary to plan the thickness of surgical skin flaps, and whether skin can be preserved for esthetics results. This study aimed to find an ultrasound-measured cut-off distance between tumor and skin (TSD) that allows patients to have the skin over the tumor spared. METHODS: This is a diagnostic accuracy study comparing preoperative ultrasound TSD with pathological TSD and the thickness of the skin flaps. We recruited all consecutive women diagnosed with breast cancer between January 2017 and December 2019 whose surgical planning allowed to have the tumor and overlying skin to be removed in bloc (reconstruction procedures, situations where skin removal would not lead to esthetic problems, and superficially located tumors)...
May 2023: Breast Care
https://read.qxmd.com/read/37261132/impact-of-the-national-action-plan-for-antimicrobial-resistance-on-antibiotic-use-for-mastitis-using-a-japanese-nationwide-database
#7
JOURNAL ARTICLE
Takaaki Konishi, Michimasa Fujiogi, Misuzu Sato, Nobuaki Michihata, Hiroki Matsui, Kotoe Nishioka, Masahiko Tanabe, Yasuyuki Seto, Hideo Yasunaga
INTRODUCTION: Mastitis is the inflammation of the mammary gland that mainly occurs during the lactation period and requires antibiotic treatment with little evidence for its efficacy. We investigated the effect of the National Action Plan for antimicrobial resistance aiming for appropriate antimicrobial stewardship on broad-spectrum antibiotics administration for mastitis despite the lack of a disease-specific antimicrobial agents manual. METHODS: Using a large nationwide database, an interrupted time-series analysis was performed using data from 34,340 female patients who received antibiotics for mastitis between April 2012 and March 2020...
May 2023: Breast Care
https://read.qxmd.com/read/37261131/clinicopathologic-features-and-pathogens-of-granulomatous-lobular-mastitis
#8
JOURNAL ARTICLE
Yunyuan Li, Ling Chen, Chunyan Zhang, Yanwen Wang, Jun Hu, Mengyun Zhou, Xiaoyun Zhang
BACKGROUND: Granulomatous lobular mastitis (GLM) is a rare, benign, and complex breast disease that can be easily misdiagnosed as breast cancer. The etiology of GLM is unclear, and optimal treatment has not been established. METHODS: Medical records for 333 patients with GLM in recent 5 years at Longhua Hospital, Shanghai, China, were analyzed. Potential pathogens in 33 fresh tissue specimens were also analyzed using 16S rDNA sequencing technology, matrix-assisted laser desorption ionization time of flight mass spectrometry, and bacterial cultures...
May 2023: Breast Care
https://read.qxmd.com/read/37261130/associated-factors-with-breast-nurses-unplanned-interventions-in-patients-treated-for-an-early-breast-cancer
#9
JOURNAL ARTICLE
Roman Vion, Patricia Fleury, Valérie Blazejewski, Olivier Rigal, Maxime Fontanilles, Justine Lequesne, Frederic Di Fiore, Florian Clatot
BACKGROUND: The presence of a breast nurse is recommended to advise and guide early breast cancer patients before and during chemotherapy/radiation therapy, and at the end of planned treatments. Nevertheless, some patients will need extra guidance. Little is known about the predisposing factors for additional requests. AIM AND OBJECTIVE: Determine time, reasons, and risk factors for breast nurse unplanned solicitations. DESIGN AND METHODS: This monocentric retrospective study included all early breast cancer patients treated with chemotherapy during 1 year...
May 2023: Breast Care
https://read.qxmd.com/read/37261129/review-article-a-multidisciplinary-evaluation-for-advanced-supportive-care-of-breast-cancer-patients
#10
REVIEW
Adelina Petrone, Marta Carlesimo, Maria Caterina Fortuna, Fedro Alessandro Peccatori, Giovanni Codacci-Pisanelli, Raffaele Barbara, Sara Cruciani, Pier Andrea Serra, Laura Maioli, Margherita Maioli, Gloria Trocchi
BACKGROUND: Cancer cases diagnosed each year are increasing, mainly because the population is ageing and, in part, due to early detection. This implies that there are more and more persons that receive medical anticancer therapies and that are interested in maintaining their quality of life. Many oncological treatments, including chemotherapy, immunotherapy, surgery, and radiotherapy, and combined therapy are associated with cutaneous toxicity and long-term side effects to different tissues and organs...
May 2023: Breast Care
https://read.qxmd.com/read/37261128/real-world-experience-of-metronomic-chemotherapy-in-metastatic-breast-cancer-results-of-a-retrospective-unicenter-study
#11
JOURNAL ARTICLE
Slavomir Krajnak, Jana Krajnakova, Katharina Anic, Katrin Almstedt, Anne-Sophie Heimes, Valerie Catherine Linz, Amelie Loewe, Mona Wanda Schmidt, Annette Hasenburg, Marcus Schmidt, Marco Johannes Battista
INTRODUCTION: Metronomic chemotherapy (MCT) is increasingly used in oncology due to its favorable therapeutic index. There is still a lack of evidence for MCT in metastatic breast cancer (MBC). In this retrospective unicenter study, we demonstrated real-word data on MCT in MBC. METHODS: MBC patients who received metronomic oral cyclophosphamide (CTX) (50 mg daily) and methotrexate (MTX) (2.5 mg every other day), CTX and capecitabine (CAPE) (500 mg thrice daily), CTX, or vinorelbine (VRL) (30 mg daily) alone for at least 4 weeks between 2009 and 2021 were included...
May 2023: Breast Care
https://read.qxmd.com/read/37261127/oncoplastic-breast-conserving-surgery-is-there-a-need-for-standardization-results-of-a-nationwide-survey
#12
JOURNAL ARTICLE
Nansi Maliko, Thomas Schok, Nina Bijker, Michel W J M Wouters, Luc J A Strobbe, Marije J Hoornweg, Marie-Jeanne T F D Vrancken Peeters
INTRODUCTION: The NABON Breast Cancer Audit showed that more than 70% of the Dutch women undergoing surgery for breast cancer maintained their breast contour by breast-conserving surgery (BCS) or by immediate reconstruction after ablative surgery. The proportion of oncoplastic surgery applied in patients undergoing breast-conserving treatment remains unknown. The aim of our study was to assess the need for standardization of oncoplastic breast-conserving surgery (OPBCS) in an attempt to enable measurement of the quality of OPBCS...
May 2023: Breast Care
https://read.qxmd.com/read/37404836/keeping-a-breast-with-social-media-le-marteau-sans-ma%C3%A3-tre
#13
EDITORIAL
Andreas Karakatsanis, Yazan Adnan Masannat
No abstract text is available yet for this article.
April 2023: Breast Care
https://read.qxmd.com/read/37404835/the-role-of-social-media-in-breast-cancer-care-and-survivorship-a-narrative-review
#14
REVIEW
Iliana Aristokleous, Andreas Karakatsanis, Yazan A Masannat, Stavroula L Kastora
BACKGROUND: Female breast cancer (BC) is the most diagnosed cancer and the leading cause of malignancy-related death worldwide. With the widespread utilisation of the Internet, social media has presented an invaluable yet underemployed tool in the context of BC medical information dissemination, support hub formation, and patient empowerment. SUMMARY: In this narrative review, we explore the untapped potential of social media in this context, caveats, and future directions that may aid in formulating a new era of patient led, in addition to patient-centred care...
April 2023: Breast Care
https://read.qxmd.com/read/37383954/st-gallen-vienna-2023-optimization-of-treatment-for-patients-with-primary-breast-cancer-a-brief-summary-of-the-consensus-discussion
#15
REVIEW
Marija Balic, Christoph Thomssen, Michael Gnant, Nadia Harbeck
The St. Gallen Consensus Conference on early breast cancer treatment 2023 was again a live event and took place in Vienna, Austria. After 4 years and one virtual event due to the pandemic, more than 2,800 participants from over 100 countries came together in Vienna, and the 2023 St. Gallen/Vienna conference was a great success. Over 3 days, the global faculty reviewed the most important evidence published during the last 2 years and debated over controversial topics, and finally, the consensus votes aimed to define the impact of the new data on everyday routine practice...
April 2023: Breast Care
https://read.qxmd.com/read/36876173/ten-year-survival-of-breast-cancer-in-iran-a-national-study-retrospective-cohort-study
#16
JOURNAL ARTICLE
Mohammad Esmaeil Akbari, Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Mohammad Akbari
PURPOSE: This study aimed to estimate the 5- and 10-year survival rates of breast cancer in Iran. METHODS: This retrospective cohort study was performed in 2019 on breast cancer patients registered in the national cancer registry system of Iran during 2007-2014. The patients were contacted to collect their information and status (alive or dead). Age and pathological type of tumor were categorized into five groups, and the place of residence was divided into 13 regions...
February 2023: Breast Care
https://read.qxmd.com/read/36876172/cdk4-6-inhibitors-in-advanced-hr-her2-breast-cancer-a-multicenter-real-world-data-analysis
#17
JOURNAL ARTICLE
Carolin Müller, Verena Kiver, Erich-Franz Solomayer, Gudrun Wagenpfeil, Caroline Neeb, Jens-Uwe Blohmer, Alina Valik Abramian, Nicolai Maass, Florian Schütz, Cornelia Kolberg-Liedtke, Damian Johannes Ralser, Anna-Christina Rambow
PURPOSE: CDK4/6 inhibitors (CDK4/6i) combined with endocrine therapy are considered standard-of-care for first-line therapy of patients with hormone receptor positive, HER2 negative, advanced breast cancer (HR+/HER2- ABC). Superiority of combination therapy over endocrine monotherapy has been demonstrated in a multitude of randomized controlled trials (RCTs) in phase III and IV. However, RCTs reflect clinical reality only to a limited extent, as narrow inclusion criteria lead to a selected patient collective...
February 2023: Breast Care
https://read.qxmd.com/read/36876171/the-predictive-importance-of-body-mass-index-on-response-to-neoadjuvant-chemotherapy-in-patients-with-breast-cancer
#18
JOURNAL ARTICLE
Levent Emirzeoglu, Serdar Arici, Ahmet Bilgehan Sahin, Birol Ocak, Naziye Ak, Seval Ay, Elkhan Mammadov, Hande Turna, Ahmet Bilici
PURPOSE: The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish patients with local and locally advanced breast cancer. METHODS: The pathological responses for the breast and axilla were assessed according to the Miller-Payne grading (MPG) system. Tumors were grouped into molecular phenotypes and classified as response rates according to the MPG system after the completion of NACT...
February 2023: Breast Care
https://read.qxmd.com/read/36876170/effectiveness-of-peer-support-on-quality-of-life-and-anxiety-in-breast-cancer-patients-a-systematic-review-and-meta-analysis
#19
JOURNAL ARTICLE
Yingyao Tan, Meijiao Qin, Bing Liao, Lixia Wang, Guangting Chang, Fengxiang Wei, Shu Cai
BACKGROUND: Breast cancer patients report high levels of psychosocial maladjustment after hospital discharge. Peer support may play an important role in improving anxiety and quality of life in breast cancer patients. This study aimed to assess the effect of peer support on quality of life and anxiety in breast cancer patients. METHOD: A systematic review and meta-analysis of randomized controlled studies were conducted, using data sourced from PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, SinoMed, China Science and Technology Periodical Database, China National Knowledge Infrastructure, and Wanfang Data for randomized controlled trials (RCTs) from inception to October 15, 2021...
February 2023: Breast Care
https://read.qxmd.com/read/36876169/a-preliminary-study-of-ultrasound-guided-microwave-ablation-for-nonpuerperal-mastitis-treatment
#20
JOURNAL ARTICLE
Shengluan Zhou, Chenyi Sheng, Ping Hu, Xuejun Ni, Xiaoping Xu, Qian Song, Xiaoxiao Jiang, Hui Zhao, Xiaoyang Chen
INTRODUCTION: This study investigated the feasibility of ultrasound (US)-guided microwave ablation (MWA) as a treatment for nonpuerperal mastitis (NPM). METHODS: Fifty-three patients with NPM diagnosed by biopsy and treated with US-guided MWA at the Affiliated Hospital of Nantong University between September 2020 and February 2022 were classified according to whether they underwent MWA alone ( n = 29) or MWA with incision and drainage ( n = 24). Patients were followed up by interviews, physical and US examinations, and evaluation of breast skin at 1 week and 1, 2, and 3 months after treatment...
February 2023: Breast Care
journal
journal
41130
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.